Pre-treatment carcinoembryonic antigen and outcome of patients with rectal cancer receiving neo-adjuvant chemo-radiation and surgical resection: a systematic review and meta-analysis
- 151 Downloads
Neo-adjuvant chemo-radiation is the standard of care for patients with locally advanced rectal carcinoma. The aim of the present paper is to evaluate the relationship of the baseline serologic concentration of the carcinoembryonic antigen with the outcome. Data sources included MEDLINE and Web of Science databases. A systematic search of the databases by a predefined criterion has been conducted. Chemo-radiation followed by surgical resection of rectal tumors was the intervention of interest. From selected studies, the relationships between carcinoembryonic antigen and pathologic complete response, disease-free survival and overall survival were assessed. Carcinoembryonic antigen correlated significantly and inversely with the rate of pathologic complete responses (OR 2.00). Similar to this relationship, a low baseline carcinoembryonic antigen concentration was associated with a better disease-free survival (OR 1.88) and a better overall survival (OR 1.85). Heterogeneity of studies and publication bias were considerable in evaluating the relationship of baseline carcinoembryonic antigen and pathologic complete response. Baseline carcinoembryonic antigen should be regarded as a predictor of outcome of patients undergoing neo-adjuvant chemo-radiation. A calibration of the cutoff value from 5 to 3 ng/ml appears more appropriate to this patient population and should be evaluated in prospective trials.
KeywordsCarcinoembryonic antigen Rectal cancer Chemo-radiation Prognosis
Compliance with ethical standards
Conflict of interest
This article does not contain any studies with human participants performed by any of the authors.
- 2.Ferrari L, Fichera A. Neoadjuvant chemotadiation therapy and pathological complete response in rectal cancer. Gastroenterol Rep. 2015;3:277–88.Google Scholar
- 8.Buijsen J, van Stiphout RG, Menheere PPCA, Lammering G, Lambin P. Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: a prospective, hypothesis driven study on patients with locally advanced rectal cancer. Radiother Oncol. 2014;111:237–42.CrossRefPubMedGoogle Scholar
- 19.Park JW, Lim S-B, Kim DY, Jung KH, Hong YS, Chang HJ, et al. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery. Int J Radiat Oncol Biol Phys. 2009;74:810–7.CrossRefPubMedGoogle Scholar
- 21.Kim TH, Chang HJ, Kim DY, Jung KH, Hong YS, Kim SY, et al. Pathologic nodal classification is he most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Int J Radiat Biol Phys. 2010;77:1158–65.CrossRefGoogle Scholar
- 30.Lee JH, Kim SH, Jang HS, Chung HJ, Oh ST, Lee DS, et al. Preoperative elevation of carcinoembryonic antigen predicts poor tumor response and frequent distant recurrence for patients with rectal cancer who receive preoperative chemoradiotherapy and total mesorectal excision: a multi-institutional analysis in an Asian population. Int J Colorectal Dis. 2013;28:511–7.CrossRefPubMedGoogle Scholar
- 41.Lee JH, Kim DY, Kim SH, Cho HM, Shim BY, Kim TH, et al. Carcinoembryonic antigen has prognostic value for tumor downstaging and recurrence in rectal cancer after preoperative chemoradiotherapy and curative surgery: a multi-institutional and case-matched control study of KROG 14-12. Radiother Oncol. 2015;116:202–8.CrossRefPubMedGoogle Scholar
- 44.Chung MJ, Nam TK, Jeong JU, Kim SH, Kim K, Jang HS, et al. Can serum dynamics of carcinoembryonic antigen level during neoadjuvant chemoradiotherapy in rectal cancer predict tumor response and recurrence? A multi-institutional retrospective study. Int J Colorectal Dis. 2016;31:1595–601.CrossRefPubMedGoogle Scholar
- 46.Sung SY, Son SH, Kay CS, Lee YS. Prognosis can be predicted more accurately using pre- and postchemoradiotherapy carcinoembryonic antigen levels compared to only prechemoradiotherapy carcinoembryonic antigen level in locally advanced rectal cancer patients who received neoadjuvant chemoradiotherapy. Medicine. 2016;95:e2965.CrossRefPubMedPubMedCentralGoogle Scholar
- 47.Bonnetain F, Bossett JF, Gerard JP, Calais G, Conroy T, Mineur L, et al. What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question? Eur J Cancer. 2012;48:1781–90.CrossRefPubMedGoogle Scholar